Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06646614 · ClinicalTrials.gov registry record · NA

Group Advanced Care Planning Pilot for Veterans

A NA study of Cancer, sponsored by VA Palo Alto Health Care System.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06646614 is a NA study of Cancer that is actively recruiting participants, run by VA Palo Alto Health Care System. The registered enrollment target is 50 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06646614, a NA study of Cancer, is actively recruiting participants, sponsored by VA Palo Alto Health Care System.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The proposed research aims to engage participants in group educational sessions to facilitate learning of topics related to advanced care planning and to determine whether this approach is more effective than usual care alone.

Conditions Studied

Interventions

  • BEHAVIORAL Group Advance Care Planning Education

Study Locations (1)

California

  • VA Palo Alto - Palo Alto

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-07-15
Est. Completion 2027-12-01
Phase NA

Sponsor

VA Palo Alto Health Care System

34 total trials

What the Registry Record Tells You About NCT06646614

The ClinicalTrials.gov registry entry for NCT06646614 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is VA Palo Alto Health Care System, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Group Advance Care Planning Education is the first listed.

NCT06646614 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06646614 about?

NCT06646614 is a clinical study titled "Group Advanced Care Planning Pilot for Veterans". The proposed research aims to engage participants in group educational sessions to facilitate learning of topics related to advanced care planning and to determine whether this approach is more effective than usual care alone.

What is the current status of trial NCT06646614?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-07-15. Estimated completion is 2027-12-01.

What conditions does trial NCT06646614 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT06646614?

The interventions under investigation include: Group Advance Care Planning Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT06646614?

This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06646614 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.